Chemical instability and promiscuity of arylmethylidenepyrazolinone-based MDMX inhibitors

Targeting the protein-protein interaction between p53 and MDM2/MDMX (MDM4) represents an attractive anticancer strategy for the treatment of p53-competent tumors. Several selective and potent MDM2 inhibitors have been developed and entered the clinic; however, the repertoire of MDMX antagonists is s...

Full description

Bibliographic Details
Main Authors: Stefaniak, J, Lewis, A, Conole, D, Galan, S, Bataille, C, Wynne, G, Castaldi, M, Lundbäck, T, Russell, A, Huber, K
Format: Journal article
Language:English
Published: American Chemical Society 2018